期刊文献+

羟基喜树碱和奥沙利铂联合应用对大肠癌细胞凋亡的影响 被引量:2

Oxaliplatin Combined with Hydroxycampothecin Chemotherapy on Apoptosis of Human Colorectal Cancer Cell Line
下载PDF
导出
摘要 目的:探讨羟基喜树碱(Hydroxycampothecin,HCPT)、奥沙利铂(Oxaliplatin,L-OHP)两药联合对人大肠癌细胞株的作用机制。方法:建立人大肠癌裸鼠实验动物模型,腹腔内注入HCPT、L-OHP及HCPT+L-OHP后,观察细胞凋亡形态,流式细胞仪分析细胞凋亡比率及细胞周期的变化。结果:HCPT组和HCPT+L-OHP组肿瘤结节较用药前及对照组明显缩小。并均以细胞凋亡为主,HCPT+L-OHP组细胞凋亡率明显高于HCPT组和对照组(P<0.05),L-OHP组主要表现为细胞坏死。HCPT组及HCPT+L-OHP组阻滞细胞周期于S期,而HCPT+L-OHP对S期的阻滞作用明显高于其他各组。结论:HCPT+L-OHP对大肠癌细胞株有较好的抑制作用,其作用机理有可能是通过L-OHP加强HCPT诱导大肠细胞凋亡发挥抗肿瘤作用,并主要作用于细胞周期的S期,使S期细胞减少。 Objective: To observe the effect of HCPT, L-OHP and their mechanism of action for combined chemotherapy on human colorectal cancer cell lines. Methods: Naked mice model for human colorectal cancer cell line was established, and HCPT, L-OHP, L-OHP+HCPT were then injected into mice's peritoneal cavity respectively. Apoptosis of cancer cells was measured by flow cytometry; electron microscope observation cellular type and the apoptosis rate. Furthermore, two different flow cytometric methods were used to analyze the cycle specificity of apoptosis. Results: The results showed that the size of subcutaneous transplantation tumor on nude mice was significantly decreased in HCPT and HCPT+L-OHP group, compared to the pre-treatment or control group. Both the HCPT and HCPT+L- OHP group showed apoptosis in tumor mass, as compared with the HCPT and control group, and the apoptosis rate was obviously increased in HCPT+ L- OHP group (P〈0.05). The L-OHP group mainly exhibited cell necrosis. In HCPT+ L-OHP group most apoptotic cells were observed in S phase of the cell cycle. Conclusion: HCPT+L-OHP is an effective therapy to human colorectal cancer cell line, which mechanism probably is L-OHP enhances the role of HCPT in induces the apoptosis of colorectal cancer. And there is a synergistic interaction in the two drugs in S phase of the cell cycle.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2006年第6期349-352,共4页 Chinese Journal of Clinical Oncology
基金 上海市卫生局青年基金资助(编号:044Y09)
关键词 大肠癌 细胞凋亡 羟基喜树碱 奥沙利铂 Colorectal cancer Apoptosis Hydroxycamptothecin Oxaliplatin
  • 相关文献

参考文献11

二级参考文献13

  • 1周丽,周振英.流式细胞仪研制的技术进展[J].现代医学仪器与应用,2003,15(1):11-17. 被引量:17
  • 2Zhang R, Li Y, Cai Q, et al. Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin,an inhibitor of topoisomerase I [J]. Cancer Chemother Pharmacol, 1998,41 (4) :257-267.
  • 3Mallery SR, Shenderova A, Pei P, et al. Effects of 10hydroxycamptothecin, delivered from locally injectable poly (lactide-co-glycolide) microspheres, in a murine human oral squamous cell carcinoma regression model [J]. Anticancer Res, 2001,21(3B): 1713-1722.
  • 4Zhou JJ, Liu J, Xu B. relationship between lactone ring forms of HCPT and their antitumor activities [J]. Acta Pharmacol Sin, 2001,22(9) :827-830.
  • 5Zhang XW, Jiang JF, Xu B. Differentiation-inducing action of 10-hydroxycamptothecin on human hepatoma HepG2 cells [J]. Acta Phannacologica Sinica, 2000,21(4):364-368.
  • 6Cliby WA, Lewis KA, Lilly KK, et al. S phase and G2 arrests induced by topoisomerase I poisons are dependent on ATR kinase function [J]. J Biol Chem, 2002,277(2):1599-1606.
  • 7Cho YS, Cho-Chung YS. Antisence protein kinase A RIalpha acts synergistically with hydroxycamptothecin to inhibit growth and induce apoptosis in human cancer cells:molecular basis for combinatorial therapy [J]. Clin Cancer Res, 2003,9(3):1171-1178.
  • 8张盈华.流式细胞仪在医学检验中的应用[J].中华医学检验杂志,1997,20(4):203-204. 被引量:25
  • 9徐滨,林波海,吴维,张幼苓,胡谦,周宏伟.新型多功能流式细胞仪的研制[J].生物物理学报,1998,14(3):558-564. 被引量:7
  • 10宋云龙,张万年,季海涛,周有骏,朱驹,吕加国.喜树碱药效构象及分子内氢键对抗肿瘤活性的影响[J].中国药物化学杂志,2001,11(6):311-315. 被引量:2

共引文献90

同被引文献13

  • 1刘萍.羟基喜树碱联合化疗方案治疗大肠癌60例临床观察[J].中国肿瘤临床与康复,2004,11(4):313-314. 被引量:4
  • 2Tournigand C,Andre T,Achille E,et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study[J]. Clin Oncol,2004,22:229-237.
  • 3Borner MM,Dierich D,Stupp R,et al. Phase Ⅱ study of capecitabine and oxaliplatin in first-and second-line treatment of advanced or metastaic colorectal cancer[J]. J Clin Oncal,2002,20 (7) :1759 - 1766.
  • 4Schuller J,Cassidy J, Dumont E,et al. Preferential activation of cape-citabine in tumor following oral administration to colorectal cancer patients [ J ]. Cancer Chemother Pharmacol, 2000,45 (4) : 291 - 300.
  • 5Van Cutsem E,Twelves C, Cassidy J,et al. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patiens with metastatic colorectal cancer:result of a large phase m study [ J]. J Clin Oncol,2001,19 :4097.
  • 6Hoff PM, Nsari R, Batist G, et al. Comparison of oral capecitabine versus intravenouss fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer : result of a randomized phase Ⅲ study[J]. J Clin Oncol,2001,19 :2282.
  • 7孙燕 周际昌.临床肿瘤内科手册[M].北京:人民卫生出版社,2003.586-591.
  • 8周际昌.实用肿瘤内科学[M].北京:人民卫生出版社,2005:601~610.
  • 9Bleiberg H.Oxaliplatin (L-OHP):a new reality in colorectal cancer[J].Br J Cancer,1998,77(Suppl 4):1-3.
  • 10Gramont A,Figer A,Seymour M,et al.Treatment in advanced colorectal cancer[J].J Clin Oncol,2000,18(16):2938-2947.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部